Overview

Fluconazole Prophylaxis of Thrush in AIDS

Status:
Completed
Trial end date:
2001-11-01
Target enrollment:
Participant gender:
Summary
This is a placebo-controlled trial of intermittent fluconazole prophylaxis (200 mg orally three times a week) in the prevention of thrush.
Phase:
Phase 4
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Fluconazole